Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: J Infect Dis. 2010 Jun 1;201(11):1686–1696. doi: 10.1086/652420

Figure 1.

Figure 1

A. Plasma HIV-1 RNA, log10 copies/mL, subject-specific trajectories shown in black, median values shown in blue. Vertical line shows study week at which last injection of pegylated-interferon occurred. The number of subjects with available data is shown at the top of the graph.

B. Plasma HIV-1 RNA changes from baseline, log10 copies/mL, trajectories of subject-specific changes in red (three subjects with reduced dosing) and black (all other subjects). Horizontal line at zero (no change from baseline); vertical line at last weekly injection of study drug.

C. Median changes in CD4+ T-cell count (solid red lines) and percent (broken blue lines) by study week, intervals represent 90% CIs around the medians.